“ECONOMIC EVALUATION OF CYP2C19 GENOTYPE-GUIDED ANTIPLATELET THERAPY FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A SYSTEMATIC REVIEW” (2026) Proceedings of the Global Public Health Conference, 9(01), pp. 14–30. doi:10.17501/26138417.2026.9102.